{"name":"Janssen Sciences Ireland UC","slug":"janssen-sciences-ireland-uc","ticker":"","exchange":"","domain":"janssensciencesirelanduc.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Formulation M3","genericName":"Formulation M3","slug":"formulation-m3","indication":"Other","status":"phase_1"},{"name":"Rilpivirine Oral Tablet","genericName":"Rilpivirine Oral Tablet","slug":"rilpivirine-oral-tablet","indication":"Other","status":"phase_1"},{"name":"Rilpivirine formulation G002","genericName":"Rilpivirine formulation G002","slug":"rilpivirine-formulation-g002","indication":"Other","status":"phase_1"},{"name":"Rilpivirine formulation G009-01","genericName":"Rilpivirine formulation G009-01","slug":"rilpivirine-formulation-g009-01","indication":"Other","status":"phase_1"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"FTC/TDF FDC","genericName":"FTC/TDF FDC","slug":"ftc-tdf-fdc","indication":"HIV-1 infection (treatment)","status":"phase_3"}]}],"pipeline":[{"name":"Formulation M3","genericName":"Formulation M3","slug":"formulation-m3","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"FTC/TDF FDC","genericName":"FTC/TDF FDC","slug":"ftc-tdf-fdc","phase":"phase_3","mechanism":"FTC/TDF is a fixed-dose combination of two nucleoside reverse transcriptase inhibitors that block HIV reverse transcriptase to prevent viral replication.","indications":["HIV-1 infection (treatment)","HIV-1 pre-exposure prophylaxis (PrEP)"],"catalyst":""},{"name":"Rilpivirine Oral Tablet","genericName":"Rilpivirine Oral Tablet","slug":"rilpivirine-oral-tablet","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Rilpivirine formulation G002","genericName":"Rilpivirine formulation G002","slug":"rilpivirine-formulation-g002","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Rilpivirine formulation G009-01","genericName":"Rilpivirine formulation G009-01","slug":"rilpivirine-formulation-g009-01","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOZXFzV1pRNnlydDdCRHpBLVhrckZ5c3RzbzdxOXZFRmlXcWJmYnROX3BvcF81M1lhbkZud3NMRzF0YnZCWVlrbUNLVFBTSU9PNG5HRHNiWTIyS0FwNEdhOVBlSUdTSm9WZURGbVdoQ3I5cTZHeU9GdC1Xc3JyZzA5eWRHUTdiSzA?oc=5","date":"2025-12-15","type":"earnings","source":"RTE.ie","summary":"Profits fall by 34% to €4.47 billion at J&J's Irish unit - RTE.ie","headline":"Profits fall by 34% to €4.47 billion at J&J's Irish unit","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE5WVnRQV015ZHVud1dXc0ZKNzg4dndkUjZrQmVKZ3J0UnJsTUFHcjY2Z0JUZWNxM29zMV9oekVZdGl3b1h1bFFCY0xnMl9Ld2tkb2RZZHZuNDY3ck1BMnNQTUdCRV9tUmVyUmFPZWRidUEyTG53WFE?oc=5","date":"2025-12-14","type":"earnings","source":"Irish Examiner","summary":"Profits at Johnson & Johnson's Cork facility decrease by 35% - Irish Examiner","headline":"Profits at Johnson & Johnson's Cork facility decrease by 35%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxPZGVOOFREcURibGxXOUJ3allvMjhoWlpvQTBqdFdUR1VGS3R5bDVJOG5lRExoWWZKbWVSV0xhWHBUQ1REekZzLTVObVN4S2dFekRoN3VreVVFZ1FURnFSbFJBcFBMNVZzZ0E4MWZsaEw2SDF4b2tQTklmdE5ZajJ4eGJIS0VnUEJwWkRHbWJoY3NEYmZkZXYzeVNseFFWdHYxQUNHd2Fsdk1wYl9lNFR1T3FTNFRIMUppRDdJZXFLUGJsVUVRUkZUSHVDckNyOHlkRDd1UmRLOUVCMjdlU3FaX2xoQkJ2eTVmNXVEbXg4SVBxRDBkaVUzVTR6czY0Z3JvNHNQUm53Uk51R1Vzbjdj?oc=5","date":"2024-08-23","type":"pipeline","source":"Johnson & Johnson","summary":"Michaela Hagenhofer Appointed General Manager, Johnson & Johnson Innovative Medicine Ireland – Commercial Operations - Johnson & Johnson","headline":"Michaela Hagenhofer Appointed General Manager, Johnson & Johnson Innovative Medicine Ireland – Commercial Operations - J","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQaWFxS0FJZGt3UkV4OURtVEV6b01MNFl1TW9rT0M5UXZfOUFyRlNiNmVoUHdYQ2hWdEsxOEJJck1BazdsRHJMX1RDcFFaMUh5b1VDM1FVRkhXSWdQM0ZwY3JJS0hyTjd5S0VTTFh3NG1GRmhlSTdYNEtXcUF6aG5wUU1QQVY3cHdxTDdkTlZ1ZDFGQ1F5OXp6LURxc1BqRS1JV1ZXYWllazI1dmlNeWowRHV1MHFsN2NKdWZ4bw?oc=5","date":"2024-06-19","type":"pipeline","source":"Johnson & Johnson","summary":"Janssen to adopt Johnson & Johnson brand in Ireland - Johnson & Johnson","headline":"Janssen to adopt Johnson & Johnson brand in Ireland - Johnson & Johnson","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE1EMDl0WEFOUHhyYzJVaVJBX0JONzd4NHlCaUlwblFyMDI2MjhXWFJQZVdSeUUzaGdLb0c2QWFSQWFDOFFDb3NKZHJJTGIwV0tCMVF5bFlRNUNDUTJpMlI5WXVoWQ?oc=5","date":"2024-06-19","type":"pipeline","source":"businessplus.ie","summary":"Janssen to rebrand as Johnson & Johnson in Ireland - businessplus.ie","headline":"Janssen to rebrand as Johnson & Johnson in Ireland","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNN1JiUl9pNFoyTVJBYzJVOHFtQURBck02UmU4MkZnU1RZd2xjdjlYS3FueHc1RnVQS05Malpuekt1SHR3dlJlZjJ0eE5WWHc1YV9MLXAyODlmUWdwRGFtMWNxMWd0M01HcDN2ZUEzdnVib2JXWV9zZGZlOUQxYWVRMFVvMjVYaHBiUHNaLUVuSjBWelpLVXNHanpzdGZlX2FLZHcw?oc=5","date":"2024-06-19","type":"pipeline","source":"imt.ie","summary":"Janssen to adopt Johnson & Johnson brand in Ireland - imt.ie","headline":"Janssen to adopt Johnson & Johnson brand in Ireland","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQS282RF9hSHhhZjktZW9XSG50TUIyYUpzVnVhdDQ4dEhJU1hSZlQtTHdTLWpvUktkbnRiZl9IWUgzRXVjdFhfV05ockZPMjI3SXdub21LX2d6MkNnOTdDTFQ4b01aZElsVjFTZF94OGFNZ2dXSHZOaDZWRjJ6am1FazFFU2EyTndWRS1BWnNMWDNOYWtYMUl4V19KeUgxRlRhbGpndWp5SXZNV2x4clE?oc=5","date":"2020-09-17","type":"pipeline","source":"ENR","summary":"Best Project, Health Care: BioCork2: Janssen Sciences Ireland Plant Expansion - ENR","headline":"Best Project, Health Care: BioCork2: Janssen Sciences Ireland Plant Expansion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPUEhBZzUtdDlrZWFsR2s2bDBxTk02MnJSaWRMZGJKNzVfMElYdzBSdVB3QWJoQkdXLW9YdlMwWjNERXRDeTF1dTFST3dKUElHNmd6TUN6aHQxdXVlQ2RaT0FBS0kyMkRhcFdNVmpRa0ZSdldSdjE5OTFCeE1uRG9aaWpxRUM2Qk1QZkFfUGVBSmRZVXE1UGVWRkpUWUNjRlhJdzRKb05JNDEyZjltNHF3Qkxsa3FRQQ?oc=5","date":"2019-10-07","type":"pipeline","source":"TheCork.ie","summary":"Janssen Sciences opens new manufacturing facility in Ringaskiddy, Co Cork, Ireland - TheCork.ie","headline":"Janssen Sciences opens new manufacturing facility in Ringaskiddy, Co Cork, Ireland","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxQNHcxalFNX3dQaG1CLUJPVnpCbGhPRWp1ZFB0WXlmUk1HMDgyVzNpaWZpbUdpNnVJdXJqMXJIWEgya0NLMHlLelBjejk4WDd1TUFtZzJkREpVSkR5Y1hPSHZOZ1UyY2VHb0JMSzRZZFlCQURfNFYzNW10VFhhdFhRX1Z3eEJIcE9kTXhDSERvWlZBZU5lSE11WmRSUkFJYVdVUzR3RnVVNHZoTHUwcEN2VTJWWjFtRUJMOVdPVXY4eDdmS1FSdGg3M09xQjgyd2pLVGYxVnpQRERkNlVRd1BEd3AtTGJPSDlHd1MyNE56UXFsNURoNzVGRWZqTzRmOXE2RXJMMm1jLWsxUQ?oc=5","date":"2018-11-26","type":"regulatory","source":"us.gsk.com","summary":"Juluca (dolutegravir/rilpivirine), the first single pill, 2-drug regimen, for the maintenance treatment of HIV, granted marketing approval - us.gsk.com","headline":"Juluca (dolutegravir/rilpivirine), the first single pill, 2-drug regimen, for the maintenance treatment of HIV, granted ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOaVlHNUVlSWNHb1pSZldWTjE2bmRGd0hSQ3RCal91Y19HdHFIM3pHaVlUQ0VRQWlTRWU1WXhrR2lDbTF4R3NwdUx3aEl4N281UHREbHkzblc3Y2Q2N0ttLXNDUlhGQ3dvTjAxRzFVck1RU1ZNbHhBdk5hUWNpb0VYVUF5b3dCX3FNZGVldkFjU0ZoRWRCcWJxNHhOWk1NMklPVml2QzByUHV3WWdwQVNLY3J3?oc=5","date":"2018-07-18","type":"pipeline","source":"Bloomberg.com","summary":"J&J Unit to Sell Sylvant Rights to U.K. Drugmaker Eusa Pharma - Bloomberg.com","headline":"J&J Unit to Sell Sylvant Rights to U.K. Drugmaker Eusa Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE9La2hWZXRubmxxbUN2dXg2TlFfZXdJNHJVcVNLcnEzRDMzcXkxQ2dXT2FIMzUzcFVsTU9iQ3JkbTJxU3dfcGpadmk2eHZHVFRyazZZRUY5SmRqMzk3V3BQcXdtcV9xQlN0MkE?oc=5","date":"2018-05-24","type":"deal","source":"Trinity College Dublin","summary":"New Partnership between Janssen Sciences Ireland and the Trinity Centre for People with Intellectual Disabilities - Trinity College Dublin","headline":"New Partnership between Janssen Sciences Ireland and the Trinity Centre for People with Intellectual Disabilities","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOa1ppcWpwMTRqSXhmcEZsTnpzbWcwcU1fejhOYTgxQU55Wm9ycjhIbGVZeEk3amlTWWpYWUhOVTJKRDdIbnA3dGhEQkNOTmtqWWNiT09JYUp1WVVaTTdwOFJlUUlwa09kdGpoeXppTUppRFdlS01lN0Rtdnk1ZnZTM2pSdDBlVG9qWUNldGFhUjZkTmpkUkNVaEItVVpiaWh3d04xTg?oc=5","date":"2017-11-21","type":"regulatory","source":"drugdiscoverytrends.com","summary":"FDA Approves First Two-Drug Regimen For Certain Patients With HIV - drugdiscoverytrends.com","headline":"FDA Approves First Two-Drug Regimen For Certain Patients With HIV","sentiment":"positive"}],"patents":[],"drugCount":5,"phaseCounts":{"phase_1":4,"phase_3":1},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}